Alkyl Amines Chemicals Ltd
Alkyl Amines Chemicals Ltd
ChemicalsKey Fundamentals
MicrocapSpecialty ChemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Alkyl Amines Chemicals Ltd insights
38 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 30.1%
Weaknesses
2- The company has delivered a poor sales growth of 4.33% over past five years.
- Company has a low return on equity of 12.8% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Alkyl Amines Chemicals Ltd is a nearly debt-free specialty chemicals company with a market cap of ₹9,144 Cr trading at a PE of 50.8x. The company faces a period of declining sales and profit growth with TTM revenue contracting 2% and profits down 3%, while its 10-year track record shows compounded sales growth of 12% and profit growth of 14%.
- Company is almost debt-free, having actively reduced debt, which provides financial flexibility and lower interest burden
- Strong 10-year compounded sales CAGR of 12% demonstrates long-term revenue scaling ability in specialty chemicals
- 10-year compounded profit growth of 14% indicates historically robust earnings power over a full business cycle
- 10-year average ROE of 21% reflects a historically high-quality capital allocation track record
- Healthy dividend payout ratio of 30.1% signals management commitment to returning capital to shareholders
- 10-year stock CAGR of 30% shows significant long-term value creation for shareholders despite recent correction
- Price-to-book of 5.96x combined with near-zero debt suggests the premium is backed by asset quality rather than leverage
- Current dividend yield of 0.56% provides some income cushion during the ongoing growth slowdown phase
- PE ratio of 50.8x is elevated, especially given TTM sales decline of 2% and profit decline of 3%, suggesting the stock prices in growth that is not materializing
- 5-year compounded sales growth of only 4% signals a structural slowdown from the 12% 10-year CAGR
- 5-year compounded profit CAGR is negative at -9%, indicating sustained earnings deterioration over a meaningful period
- ROE has declined from a 10-year average of 21% to just 12% last year, reflecting diminishing returns on equity capital
- 3-year ROE of 13% versus 5-year ROE of 16% shows a continuing downward trajectory in profitability
- Stock has declined 24% over the past 1 year and shows a 3-year CAGR of -10%, indicating sustained de-rating by the market
- 3-year compounded sales growth of -3% suggests the revenue contraction is not a one-off but a multi-year trend
- 5-year stock CAGR of -16% indicates prolonged destruction of shareholder value from peak levels
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- ₹10 dividend declared at AGM Jul 3
Alkyl Amines declared a dividend of ₹10 per share at its 46th AGM on July 3, 2026. The company also highlighted capacity expansion plans and received anti-dumping duty approval, supporting margin protection.
TL;DR: Alkyl Amines is rewarding shareholders with a ₹10/share dividend while investing in capacity expansion. The anti-dumping duty approval provides a protective tailwind against cheap imports. No visible headwinds from recent news, though limited data makes it difficult to assess broader trend direction. The combination of growth capex and trade protection suggests management confidence in near-term demand.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 410 | 352 | 322 | 357 | 400 | 415 | 371 | 386 | 406 | 389 | 354 | 387 | 528 |
| Expenses | 336 | 304 | 262 | 288 | 321 | 341 | 301 | 318 | 329 | 319 | 287 | 316 | 394 |
| Operating Profit | 74 | 48 | 60 | 69 | 79 | 74 | 71 | 68 | 77 | 70 | 67 | 71 | 134 |
| OPM % | 18% | 14% | 19% | 19% | 20% | 18% | 19% | 18% | 19% | 18% | 19% | 18% | 25% |
| Other Income | 5 | 2 | 5 | 3 | 5 | 9 | 7 | 9 | 8 | 7 | 8 | 8 | 9 |
| Interest | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 12 | 13 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| PBT | 66 | 36 | 46 | 53 | 66 | 64 | 59 | 59 | 66 | 59 | 57 | 61 | 125 |
| Tax % | 25% | 25% | 28% | 28% | 26% | 26% | 26% | 22% | 25% | 27% | 26% | 25% | 24% |
| Net Profit | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 | 42 | 45 | 95 |
| EPS in Rs | 9.74 | 5.33 | 6.54 | 7.52 | 9.56 | 9.28 | 8.56 | 9 | 9.67 | 8.4 | 8.26 | 8.87 | 18.5 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,572 | 1,536 | 1,658 |
| Expenses | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,280 | 1,251 | 1,317 |
| Operating Profit | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 291 | 285 | 342 |
| OPM % | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 19% | 19% | 21% |
| Other Income | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 30 | 32 | 33 |
| Interest | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 1 | 1 | 1 |
| Depreciation | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 71 | 72 | 72 |
| PBT | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 249 | 243 | 302 |
| Tax % | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | 25% | 26% | — |
| Net Profit | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 186 | 180 | 225 |
| EPS in Rs | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 36.39 | 35.19 | 44.03 |
| Div. Payout % | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% | 28% | 28% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 | 1,392 | 1,523 |
| Borrowings | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | 6 | 1 |
| Other Liabilities | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | 381 | 362 |
| Total Liabilities | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,896 |
| Fixed Assets | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | 1,044 | 1,015 |
| CWIP | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 | 52 | 130 |
| Investments | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 | 0 | 51 |
| Other Assets | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | 693 | 700 |
| Total Assets | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,896 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 61 | 101 | 63 | 102 | 144 | 188 | 364 | 205 | 248 | 275 | 263 | 239 |
| Investing | -31 | -35 | -65 | -132 | -67 | -41 | -213 | -206 | -277 | -121 | -196 | -137 |
| Financing | -36 | -68 | -2 | 32 | -60 | -135 | -86 | -57 | 8 | -140 | -49 | -56 |
| Net Cash Flow | -6 | -2 | -3 | 2 | 17 | 12 | 65 | -58 | -21 | 13 | 18 | 45 |
| Free Cash Flow | 20 | 66 | -1 | -33 | 75 | 111 | 208 | -41 | -55 | 153 | 216 | 111 |
| CFO/OP | 95 | 128 | 88 | 103 | 109 | 96 | 108 | 86 | 92 | 123 | 108 | 101 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 | 54 | 55 |
| Inventory Days | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 | 75 | 57 |
| Days Payable | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 | 80 | 70 |
| Cash Conversion Cycle | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 | 48 | 42 |
| Working Capital Days | 93 | 87 | 84 | 76 | 56 | 54 | 26 | 35 | 28 | 47 | 42 | 49 |
| ROCE % | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% | 19% | 17% |
Documents
Frequently Asked Questions about Alkyl Amines Chemicals Ltd
What does Alkyl Amines Chemicals Ltd do?
Where is Alkyl Amines Chemicals Ltd (ALKYLAMINE) listed?
Which sector does Alkyl Amines Chemicals Ltd belong to?
What is the market capitalisation of Alkyl Amines Chemicals Ltd?
What is the PE ratio of Alkyl Amines Chemicals Ltd?
What is the 52-week high and low of Alkyl Amines Chemicals Ltd?
Does Alkyl Amines Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Alkyl Amines Chemicals Ltd?
How can I research Alkyl Amines Chemicals Ltd on Tapetide?
Company Information
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.